- Process engineer, Precision Valve Corporation, 1984-1988
Education
- Pace University, J.D., 1990, Dean’s List
- University of Massachusetts Amherst, B.S., 1984
Bar Admissions
- New York
Court Admissions
- U.S. District Court, Southern District of New York
- U.S. District Court, Eastern District of New York
- U.S. District Court, Northern District of New York
- U.S. Court of Appeals, Federal Circuit
- Speaker, “Charting the Evolving Boundaries of the Safe Harbor 35 USC § 271 in View of Recent Case Law,” ACI 21st Annual Paragraph IV Disputes 2025, April 29, 2025.
- Speaker, “Appreciating the Magistrate5’s Role in Settlement Discussions,” 14 Annual Paragraph IV Disputes Conference, October 6, 2020.
- Panelist, “Preparing for the Future: Calling Attention to Products Coming Off-Patent and Devising Forward-Thinking Portfolio Strategies,” ACI Biosimilars Conference, September 2020.
- Speaker, “Preparing for the Future: Calling Attention to Biological Products Coming Off-Patent and Devising Forward-Thinking Portfolio Strategies,” 11 ACI Summit on Biosimilar & Innovator Biologics, September 24, 2020.
- Speaker, “ANDA Filing and Litigation,” 9 Annual Pharma IP Conference, March 4-6, 2020.
- Co-author, “Back to Basics: Despite Winning the Appeal, Failure to Appeal a Preliminary Injunction Bond Constituted Waiver of Damages,” Locke Lord QuickStudy, July 31, 2024.
- Co-author, “How Much Claim Construction Significance? – Extrinsic Evidence and Significant Figures,” Locke Lord QuickStudy, November 14, 2023.
- Co-author, “Impact of US v. Arthrex,” Locke Lord QuickStudy, July 29, 2021.
- Co-author, “Bayer v. Baxalta: Meeting the Large Molecule Enablement Bar,” Locke Lord QuickStudy, March 23, 2021.
- Co-author, “Functional Antibody Claims: Setting the Bar for Enablement,” Locke Lord QuickStudy, February 12, 2021.